Antonella was a co-founder of Okairos and served as the company’s Director of Immunology. Her experience includes the positions of Researcher and Group Leader at IRBM, where she focused her research interest in the field of diagnosis and prevention of chronic infectious diseases and contributed to the implementation and validation of a novel vaccine platform technology. In Okairos she significantly contributed to the preclinical and clinical validation of several vaccine programs.
Antonella has authored many scientific publications in peer reviewed journals on a range of subjects, including peptide phage display technology, immunology, viral infections and vaccines. She is a named inventor in several patents.
Antonella received her degree in Biology and a PhD in Molecular and Cellular Biology from the University of Rome, La Sapienza and conducted post-doctoral studies in immunology at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) in Strasbourg, France.